Astellas Pharma Inc (ALPMY)
9.59
+0.05
(+0.52%)
USD |
OTCM |
Apr 26, 13:46
Astellas Pharma Shareholders Equity (Quarterly): 10.66B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 10.66B |
September 30, 2023 | 10.97B |
June 30, 2023 | 10.90B |
March 31, 2023 | 11.32B |
December 31, 2022 | 11.98B |
September 30, 2022 | 11.42B |
June 30, 2022 | 11.27B |
March 31, 2022 | 11.96B |
December 31, 2021 | 12.74B |
September 30, 2021 | 12.66B |
June 30, 2021 | 12.51B |
March 31, 2021 | 12.57B |
December 31, 2020 | 13.27B |
September 30, 2020 | 12.58B |
June 30, 2020 | 12.14B |
March 31, 2020 | 11.93B |
December 31, 2019 | 12.10B |
September 30, 2019 | 12.01B |
June 30, 2019 | 11.58B |
March 31, 2019 | 11.35B |
December 31, 2018 | 11.71B |
September 30, 2018 | 11.28B |
June 30, 2018 | 11.54B |
March 31, 2018 | 11.93B |
December 31, 2017 | 12.12B |
Date | Value |
---|---|
September 30, 2017 | 12.01B |
June 30, 2017 | 11.78B |
March 31, 2017 | 11.38B |
December 31, 2016 | 11.29B |
September 30, 2016 | 12.12B |
June 30, 2016 | 11.58B |
March 31, 2016 | 11.20B |
December 31, 2015 | 10.98B |
September 30, 2015 | 11.04B |
June 30, 2015 | 10.87B |
March 31, 2015 | 10.98B |
December 31, 2014 | 11.50B |
September 30, 2014 | 11.84B |
June 30, 2014 | 12.13B |
March 31, 2014 | 12.33B |
December 31, 2013 | 11.06B |
September 30, 2013 | 11.47B |
June 30, 2013 | 11.06B |
March 31, 2013 | 12.47B |
December 31, 2012 | 12.23B |
September 30, 2012 | 12.92B |
June 30, 2012 | 12.40B |
March 31, 2012 | 13.67B |
December 31, 2011 | 12.79B |
September 30, 2011 | 12.77B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
10.66B
Minimum
Dec 2023
13.27B
Maximum
Dec 2020
11.92B
Average
11.98B
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 47.81B |
Nxera Pharma Co Ltd | 473.75M |
PeptiDream Inc | 286.12M |
Stemcell Holdings Inc | 6.009M |
Healios KK | 27.34M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 23.89B |
Total Liabilities (Quarterly) | 13.23B |
Debt to Equity Ratio | 0.5794 |
Current Ratio | 0.9102 |
Net Debt Paydown Yield | -5.79% |